Introduction

Anand Iyer, Chief Strategy Officer at WellDoc, discusses his role and background in the healthcare industry, including his involvement in the development of Bluestar, the first FDA-cleared mobile prescription therapy for adults with Type 2 diabetes, and his achievements in mobile health innovation.